Skip to content

Effect of bathroom with Chicory on bilirubin levels on neonatal with hyperbilirubinemia

effect of bathroom with Chicory on bilirubin levels on neonatal with hyperbilirubinemia

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015122225619N2
Enrollment
64
Registered
2015-12-27
Start date
2016-01-11
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal icterus. Neonatal jaundice from other and unspecified causes

Interventions

Intervention 1: In the experimental group except phototherapy, after noon feeding that phototherapy is stopped the baby will be bathed with Chicory1 time daily for 2 days. Then at baseline and at the
Treatment - Drugs
In the experimental group except phototherapy, after noon feeding that phototherapy is stopped the baby will be bathed with Chicory1 time daily for 2 days. Then at baseline and at the end of the study
Control group only will be treated with phototherapy. Then at baseline and at the end of the study, baby's body temperature will measured. And infants will placed under individually or a broad phototh

Sponsors

Vice chancellor for research, Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
9 Months to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: no anomalies and congenital infection;infants with equal to or more than 35 weeks gestational age( and weighing more than 2200 g); hyperbilirubinemia that requiring phototherapy;been Breastfeeding Exclusion criteria:Type of hemolytic hyperbilirubinemia; deficiency in G6PD and Combs; hyperbilirubinemia that need to replace blood; History of skin allergy in the family or any sensitivity to Chicory in newborn; Parents unwillingness to continue; discharge or death of newborn.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Tanning baby syndrome. Timepoint: Baseline and end of study (48 hours after the start of the study). Method of measurement: Observed by doctor.;Diarrhea. Timepoint: Baseline and end of study (48 hours after the start of the study). Method of measurement: Observed by doctor.;Skin rash. Timepoint: Baseline and end of study (48 hours after the start of the study). Method of measurement: Observed by doctor.;Bilirubin level. Timepoint: Baseline and end of study (48 hours after the start of the study). Method of measurement: In laboratory by photometer device.;Hyperthermia. Timepoint: Baseline (before the bathroom) and after bathroom (for two days, each day once). Method of measurement: Using a mercury thermometer.;Dehydration. Timepoint: Baseline (before the bathroom) and after bathroom (for two days, each day once). Method of measurement: Observed by doctor.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLeila Mohammadi Pirkashani

Kermanshah University of Medical Sciences

mohammadi.p@nm.mui.ac.ir+98 83 3427 6302

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026